calendar
4,210 catalysts · 3,070 8k filing · 576 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
next 91 dayslessmore
MonWedFri
4,210 catalysts · 3,070 8k filing · 576 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
Chocolate
Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: ASTRAZENECA AB. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: BIOGEN US. Form: CAPSULE. Route: ORAL
Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Product code: DWJ. Advisory committee: Cardiovascular. Type: Traditional
Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: LOL. Advisory committee: Microbiology. Type: Traditional
Product code: HQF. Advisory committee: Ophthalmic. Type: Traditional
Product code: SEI. Advisory committee: Microbiology. Type: Traditional
Product code: SEI. Advisory committee: Microbiology. Type: Traditional
Product code: FRO. Advisory committee: Unknown. Type: Traditional
Product code: LYZ. Advisory committee: General Hospital. Type: Traditional
Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional
Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional
Product code: LOX. Advisory committee: Cardiovascular. Type: Traditional
Product code: SHP. Advisory committee: Cardiovascular. Type: Traditional
Product code: DYB. Advisory committee: Cardiovascular. Type: Special
Product code: FAJ. Advisory committee: Gastroenterology, Urology. Type: Traditional
Supplement type: Normal 180 Day Track No User Fee. Product code: QTL. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: NOX. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: NOX. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: OZD. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30
Supplement type: Real-Time Process. Product code: LMH. Advisory committee: SU. Decision: APPR
CA grant. $660,808. PI: Christina Vadala Angeles
AI grant. $653,742. PI: Sarah Caddy
CA grant. $696,189. PI: Nikhil Joshi
NS grant. $613,161. PI: AMY LEE
ES grant. $400,398. PI: Adam Christopher Roberts
CA grant. $403,686. PI: RUTH A. KERI
AI grant. $160,100. PI: LEE ANN Garrett-Sinha
CA grant. $586,364. PI: Jianhua Yu
GM grant. $389,203. PI: Mary K Kochlefl
AI grant. $50,114. PI: Adrianna Jones
MH grant. $793,185. PI: Guochun Jiang
AI grant. $411,078. PI: Yasmina Laouar
CA grant. $544,520. PI: Tohru Yamada
AI grant. $429,000. PI: PETER MANCUSO
EB grant. $570,612. PI: Charles F Caskey
Antiseptic wound care gel bottles and tubes
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: NEUROCRINE. Form: CAPSULE. Route: ORAL